lutetium has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldridge, MD; Bomanji, JB; Gains, JE; Gaze, MN; Laidler, J; Moroz, V; Peet, C; Wan, S; Wheatley, K | 1 |
| Ametamey, S; Bläuenstein, P; Grünberg, J; Honer, M; Knogler, K; Maecke, HR; Novak-Hofer, I; Schubiger, PA; Zimmermann, K | 1 |
1 trial(s) available for lutetium and Neuroblastoma
| Article | Year |
|---|---|
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Gallium Radioisotopes; Humans; Lutetium; Neuroblastoma; Radiopharmaceuticals | 2020 |
1 other study(ies) available for lutetium and Neuroblastoma
| Article | Year |
|---|---|
In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.
Topics: Animals; Copper Radioisotopes; Humans; Immunoconjugates; Immunoglobulin Fragments; Lutetium; Mice; Mice, Nude; Neoplasms; Neural Cell Adhesion Molecule L1; Neuroblastoma; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |